Clinical trial
Oral Dexamethasone for Treatment of Migraine
NCT00216736 · The Joseph Epstein Centre for Emergency Medicine Research, Other · Completed
Key facts
| NCT number | NCT00216736 |
|---|---|
| Title | Oral Dexamethasone for Treatment of Migraine |
| Official title | Does a Single Oral Dose of Dexamethasone After Successful Emergency Treatment of Migraine Reduce the Incidence or Severity of Rebound Headache Within 48 Hours? |
| Lead sponsor | The Joseph Epstein Centre for Emergency Medicine Research, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Dexamethasone, placebo |
| Enrollment | 63 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 30, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: